Login
$SSII
$2.44 -$0.06 (2.4%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q2 FY2022
As of Jun 30, 2022
Q3 FY2022
As of Sep 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q1 FY2021
As of Mar 31, 2021
Q4 FY2021
As of Dec 31, 2021
Current Assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Inventory
Related Party
Total inventory
Prepaids and other current assets
Receivable from Related party
Total Current Assets
Equipment
Accumulated depreciation
Property, plant, and equipment, net
Total Other Assets, net
Right of use asset, net
Accounts receivable, net of allowances
Loans & Advances ( Related Party)
Deferred tax assets, net
Accounts receivable, net-non current
Restricted cash- non current
Loans & Advances (Related Party)
Total Non-Current Assets
Prepaids and other non current assets
Total Assets
Current Liabilities
Bank overdraft facility
Notes payable
Total notes payable
Current maturities of long-term debt
Current portion of operating lease liabilities
Accounts payable
Accrued compensation
Deferred tax liability
Deferred revenue
Accrued expenses & other current liabilities
Total Current Liabilities
Operating lease liabilities, less current portion
Long term Liabilities
Deferred Revenue- non current
Other non current liabilities
Related Party
Total other non current liabilities
Total Non-Current Liabilities
Total Liabilities
Stockholders’equity:
Preferred stock, authorized 5,000,000 shares of Series A, Non-Convertible Preferred Stock, $0.0001 par value per share; 1,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025
Translation adjustment
Common stock, 250,000,000 shares authorized, $0.0001 par value, 200,169,035 shares and 194,165,141 shares issued and outstanding as of June 30, 2026 and December 31, 2025 respectively
Accumulated other comprehensive loss
Common stock to be issued, 12,500 shares
Additional paid in capital
Capital reserve
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support